As of Feb 27
| +0.00026 / +11.61%|
The 1 analysts offering 12-month price forecasts for Pharmagen Inc have a median target of 0.13, with a high estimate of 0.13 and a low estimate of 0.13. The median estimate represents a +5,100.00% increase from the last price of 0.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.